Showing 1 - 20 results of 48 for search 'Volkmar Müller', query time: 0.06s
Refine Results
-
1
Brain Metastasis in Breast Cancer Patients—Need for Improvement by Isabell Witzel, Leticia Oliveira-Ferrer, Volkmar Müller
Published 2020-10-01
Article -
2
-
3
-
4
-
5
-
6
Major influencing factors on routine implementation of shared decision-making in cancer care: qualitative process evaluation of a stepped-wedge cluster randomized trial by Pola Hahlweg, Anja Lindig, Wiebke Frerichs, Jördis Zill, Henning Hanken, Volkmar Müller, Mia-Carlotta Peters, Isabelle Scholl
Published 2023-08-01
Article -
7
Immature O-glycans recognized by the macrophage glycoreceptor CLEC10A (MGL) are induced by 4-hydroxy-tamoxifen, oxidative stress and DNA-damage in breast cancer cells by Anna-Katharina Kurze, Sophia Buhs, Dennis Eggert, Leticia Oliveira-Ferrer, Volkmar Müller, Axel Niendorf, Christoph Wagener, Peter Nollau
Published 2019-08-01
Article -
8
-
9
-
10
Long-term trastuzumab (Herceptin®) treatment in a continuation study of patients with HER2-positive breast cancer or HER2-positive gastric cancer by Volkmar Müller, Michael Clemens, Jacek Jassem, Nedal Al-Sakaff, Petra Auclair, Eveline Nüesch, Debbie Holloway, Mona Shing, Yung-Jue Bang
Published 2018-03-01
Article -
11
Cysteine-Rich Angiogenic Inducer 61: Pro-Survival Function and Role as a Biomarker for Disseminating Breast Cancer Cells by Kai Bartkowiak, Isabel Heidrich, Marcel Kwiatkowski, Tobias M. Gorges, Antje Andreas, Maria Geffken, Karl Verpoort, Volkmar Müller, Hartmut Schlüter, Klaus Pantel
Published 2021-02-01
Article -
12
Evaluation of a program for routine implementation of shared decision-making in cancer care: study protocol of a stepped wedge cluster randomized trial by Isabelle Scholl, Pola Hahlweg, Anja Lindig, Carsten Bokemeyer, Anja Coym, Henning Hanken, Volkmar Müller, Ralf Smeets, Isabell Witzel, Levente Kriston, Martin Härter
Published 2018-03-01
Article -
13
Implementation analysis of patient reported outcomes (PROs) in oncological routine care: an observational study protocol by Mirja Gianna Görlach, Theresa Schrage, Carsten Bokemeyer, Nicolaus Kröger, Volkmar Müller, Cordula Petersen, Christian Stephan Betz, Andreas Krüll, Holger Schulz, Christiane Bleich
Published 2020-01-01
Article -
14
Frequent detection of PIK3CA mutations in single circulating tumor cells of patients suffering from HER2‐negative metastatic breast cancer by Christin Gasch, Theresa Oldopp, Oliver Mauermann, Tobias M. Gorges, Antje Andreas, Cornelia Coith, Volkmar Müller, Tanja Fehm, Wolfgang Janni, Klaus Pantel, Sabine Riethdorf
Published 2016-10-01
Article -
15
Targeting the TIGIT-PVR immune checkpoint axis as novel therapeutic option in breast cancer by Hauke Stamm, Leticia Oliveira-Ferrer, Eva-Maria Grossjohann, Jana Muschhammer, Vanessa Thaden, Franziska Brauneck, Roman Kischel, Volkmar Müller, Carsten Bokemeyer, Walter Fiedler, Jasmin Wellbrock
Published 2019-12-01
Article -
16
Insights into the Steps of Breast Cancer–Brain Metastases Development: Tumor Cell Interactions with the Blood–Brain Barrier by Fabienne Hamester, Christine Stürken, Ceren Saygi, Minyue Qi, Karen Legler, Christian Gorzelanny, José R. Robador, Barbara Schmalfeldt, Elena Laakmann, Volkmar Müller, Isabell Witzel, Leticia Oliveira-Ferrer
Published 2022-02-01
Article -
17
Key Role of Hyaluronan Metabolism for the Development of Brain Metastases in Triple-Negative Breast Cancer by Fabienne Hamester, Christine Stürken, Karen Legler, Kathrin Eylmann, Katrin Möller, Maila Roßberg, Christian Gorzelanny, Alexander T. Bauer, Sabine Windhorst, Barbara Schmalfeldt, Elena Laakmann, Volkmar Müller, Isabell Witzel, Leticia Oliveira-Ferrer
Published 2022-10-01
Article -
18
53BP1 Accumulation in Circulating Tumor Cells Identifies Chemotherapy-Responsive Metastatic Breast Cancer Patients by Fabienne Schochter, Kim Werner, Cäcilia Köstler, Anke Faul, Marie Tzschaschel, Barbara Alberter, Volkmar Müller, Hans Neubauer, Tanja Fehm, Thomas W.P. Friedl, Bernhard Polzer, Wolfgang Janni, Brigitte Rack, Lisa Wiesmüller
Published 2020-04-01
Article -
19
Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures. by Thomas Karn, Lajos Pusztai, Uwe Holtrich, Takayuki Iwamoto, Christine Y Shiang, Marcus Schmidt, Volkmar Müller, Christine Solbach, Regine Gaetje, Lars Hanker, Andre Ahr, Cornelia Liedtke, Eugen Ruckhäberle, Manfred Kaufmann, Achim Rody
Published 2011-01-01
Article -
20
Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer by Malgorzata Banys-Paluchowski, Tanja Fehm, Wolfgang Janni, Bahriye Aktas, Peter A. Fasching, Sabine Kasimir-Bauer, Karin Milde-Langosch, Klaus Pantel, Brigitte Rack, Sabine Riethdorf, Erich-Franz Solomayer, Isabell Witzel, Volkmar Müller
Published 2018-05-01
Article